Literature DB >> 31389006

Cardiac expression of HMOX1 and PGF in sickle cell mice and haem-treated wild type mice dominates organ expression profiles via Nrf2 (Nfe2l2).

Oluwabukola T Gbotosho1,2, Samit Ghosh1,3, Maria G Kapetanaki2,4, Yu Lin1,2, Frances Weidert2, Grant C Bullock5, Solomon F Ofori-Acquah1,2,3,6, Gregory J Kato1,2.   

Abstract

Haemolysis is a major feature of sickle cell disease (SCD) that contributes to organ damage. It is well established that haem, a product of haemolysis, induces expression of the enzyme that degrades it, haem oxygenase-1 (HMOX1). We have also shown that haem induces expression of placental growth factor (PGF), but the organ specificity of these responses has not been well-defined. As expected, we found high level expression of Hmox1 and Pgf transcripts in the reticuloendothelial system organs of transgenic sickle cell mice, but surprisingly strong expression in the heart (P < 0·0001). This pattern was largely replicated in wild type mice by intravenous injection of exogenous haem. In the heart, haem induced unexpectedly strong mRNA responses for Hmox1 (18-fold), Pgf (4-fold), and the haem transporter Slc48a1 (also termed Hrg1; 2·4-fold). This was comparable to the liver, the principal known haem-detoxifying organ. The NFE2L2 (also termed NRF2) transcription factor mediated much of the haem induction of Hmox1 and Hrg1 in all organs, but less so for Pgf. Our results indicate that the heart expresses haem response pathway genes at surprisingly high basal levels and shares with the liver a similar transcriptional response to circulating haem. The role of the heart in haem response should be investigated further.
© 2019 British Society for Haematology and John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Hmox1zzm321990; zzm321990Pgfzzm321990; haem; haemolysis; sickle cell disease

Mesh:

Substances:

Year:  2019        PMID: 31389006      PMCID: PMC8007233          DOI: 10.1111/bjh.16129

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  58 in total

1.  Nonhematopoietic Nrf2 dominantly impedes adult progression of sickle cell anemia in mice.

Authors:  Samit Ghosh; Chibueze A Ihunnah; Rimi Hazra; Aisha L Walker; Jason M Hansen; David R Archer; Amma T Owusu-Ansah; Solomon F Ofori-Acquah
Journal:  JCI Insight       Date:  2016-04-07

2.  PlGF and sFlt-1 levels in patients with non-transfusion-dependent thalassemia: Correlations with markers of iron burden and endothelial dysfunction.

Authors:  Charikleia Kelaidi; Antonis Kattamis; Filia Apostolakou; Christos Poziopoulos; Christina Lazaropoulou; Polyxeni Delaporta; Ino Kanavaki; Ioannis Papassotiriou
Journal:  Eur J Haematol       Date:  2018-04-25       Impact factor: 2.997

3.  Placental growth factor provides a novel local angiogenic therapy for ischemic cardiomyopathy.

Authors:  Stephen Kolakowski; Mark F Berry; Pavan Atluri; Todd Grand; Omar Fisher; M Astrid Moise; Jeffrey Cohen; Vivian Hsu; Y Joseph Woo
Journal:  J Card Surg       Date:  2006 Nov-Dec       Impact factor: 1.620

4.  Short-term delivery of anti-PlGF antibody delays progression of atherosclerotic plaques to vulnerable lesions.

Authors:  Carmen Roncal; Ian Buysschaert; Norbert Gerdes; Maria Georgiadou; Olga Ovchinnikova; Christian Fischer; Jean-Marie Stassen; Lieve Moons; Désiré Collen; Katrien De Bock; Göran K Hansson; Peter Carmeliet
Journal:  Cardiovasc Res       Date:  2009-12-01       Impact factor: 10.787

5.  Heme oxygenase in diabetes-induced oxidative stress in the heart.

Authors:  Hana Farhangkhoee; Zia A Khan; Suranjana Mukherjee; Mark Cukiernik; Yousef P Barbin; Morris Karmazyn; Subrata Chakrabarti
Journal:  J Mol Cell Cardiol       Date:  2003-12       Impact factor: 5.000

6.  Paradoxical protection from atherosclerosis and thrombosis in a mouse model of sickle cell disease.

Authors:  Hui Wang; Wei Luo; Jintao Wang; Chiao Guo; Stephanie L Wolffe; Julia Wang; Eddy B Sun; Kori N Bradley; Andrew D Campbell; Daniel T Eitzman
Journal:  Br J Haematol       Date:  2013-04-17       Impact factor: 6.998

Review 7.  Signaling effectors underlying pathologic growth and remodeling of the heart.

Authors:  Jop H van Berlo; Marjorie Maillet; Jeffery D Molkentin
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

8.  Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.

Authors:  John D Belcher; Chunsheng Chen; Julia Nguyen; Liming Milbauer; Fuad Abdulla; Abdu I Alayash; Ann Smith; Karl A Nath; Robert P Hebbel; Gregory M Vercellotti
Journal:  Blood       Date:  2013-11-25       Impact factor: 22.113

Review 9.  Heme oxygenase-1: unleashing the protective properties of heme.

Authors:  Leo E Otterbein; Miguel P Soares; Kenichiro Yamashita; Fritz H Bach
Journal:  Trends Immunol       Date:  2003-08       Impact factor: 16.687

10.  Placental growth factor regulates cardiac adaptation and hypertrophy through a paracrine mechanism.

Authors:  Federica Accornero; Jop H van Berlo; Matthew J Benard; John N Lorenz; Peter Carmeliet; Jeffery D Molkentin
Journal:  Circ Res       Date:  2011-06-02       Impact factor: 17.367

View more
  2 in total

Review 1.  The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease.

Authors:  Oluwabukola T Gbotosho; Maria G Kapetanaki; Gregory J Kato
Journal:  Front Immunol       Date:  2021-01-27       Impact factor: 7.561

2.  Heme Induces IL-6 and Cardiac Hypertrophy Genes Transcripts in Sickle Cell Mice.

Authors:  Oluwabukola T Gbotosho; Maria G Kapetanaki; Samit Ghosh; Flordeliza S Villanueva; Solomon F Ofori-Acquah; Gregory J Kato
Journal:  Front Immunol       Date:  2020-08-21       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.